Selected article for: "clinical course and fatality rate"

Author: Caselli, D.; Chironna, M.; Loconsole, D.; Nigri, L.; Mazzotta, F.; Bonamonte, D.; Aricò, M.
Title: No evidence of SARS‐Cov‐2 infection by PCR or serology in children with pseudochilblain
  • Cord-id: qqqu4aw2
  • Document date: 2020_7_1
  • ID: qqqu4aw2
    Snippet: Despite its aggressive clinical course, leading to 6.4% fatality rate as of May 25, 2020 (https://qap.ecdc.europa.eu/public/extensions/COVID-19/COVID-19.html), COVID‐19 turned out to be only marginally aggressive in children. In a report from Lombardy, 18/88 COVID‐19 hospitalized adults (20%) had developed cutaneous manifestations: erythematous rash, widespread urticarial, and chickenpox‐like vesicles. Trunk was the main involved region. Itching was low or absent and usually lesions healed
    Document: Despite its aggressive clinical course, leading to 6.4% fatality rate as of May 25, 2020 (https://qap.ecdc.europa.eu/public/extensions/COVID-19/COVID-19.html), COVID‐19 turned out to be only marginally aggressive in children. In a report from Lombardy, 18/88 COVID‐19 hospitalized adults (20%) had developed cutaneous manifestations: erythematous rash, widespread urticarial, and chickenpox‐like vesicles. Trunk was the main involved region. Itching was low or absent and usually lesions healed in few days. An unexpected outbreak of acute pseudochilblain skin lesions is being reported from different countries and related to COVID‐19.

    Search related documents:
    Co phrase search for related documents
    • Try single phrases listed below for: 1